Proven medicines.
New patients.
Innovative de-risked therapeutics never reach the markets that need them most. Firstocean changes that.
/the problem
Hundreds of de-risked therapies, approved by the FDA, EMA, and PMDA, never reach the emerging markets where demand is greatest.
2 in 3
FDA-approved drugs never reach LATAM, MENA, or SEA
450+
Identified Assets
$390Bn+
Untapped Value
440M+
Potential Patients
/our solution
Firstocean is the AI sourcing engine that resolves it: scoring thousands of candidates against patient populations, regulatory pathways, and commercial fit, then routing the best assets to the right partners.
Contact Us